What happened?
A Nature Aging study reports that aging hematopoietic stem cells can develop maladaptive trained immunity, generating myeloid cells that promote chronic inflammation and functional decline in mice. Increasing SIRT3 activity in the stem-cell compartment improved several age-related functional measures in the experimental model.
Why does it matter?
The work suggests that some systemic age-related inflammation may originate high upstream in blood-forming stem cells rather than simply being a passive consequence of damaged tissues.
How to interpret the evidence
This is preclinical biology. A plausible mechanism and a target in mice are not the same as a safe anti-aging therapy in humans.
What remains uncertain?
It does not mean SIRT3 supplements or unapproved 'stem-cell rejuvenation' treatments have been shown to extend human life.
Medical News provides general health education. Individual treatment decisions depend on your circumstances and the advice of your clinical team.